Doxycycline price hikes make antibiotic too expensive for pets and vets

Meteoric price rise of drug was great for Hikma but hard on animals with Lyme disease

August 5, 2014 | By Eric Palmer

                                          

 

A shortage of the antibiotic doxycycline powered huge price increases, in turn providing a huge boon for drugmakers like Jordan-based drugmaker Hikma, which rode that wave to big revenue increases. But even though the FDA declared the shortage of the drug over last year, prices remain high, keeping the first-line treatment for Lyme disease out of reach for one particular market segment: pets and vets.
continue to read here